Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Ghurulakshmi Moorthy

Internal Medicine Urbana, IL Medical Doctor

NPI 1639434814 CMS profile 438627

611 W Park St, Carle Forum Ll, Urbana, IL 61801

Open in the dashboard

General payments

$8,034

403 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Ghurulakshmi Moorthy of Urbana, IL is reported in the CMS Open Payments database as having received $8,034 across 403 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Internal Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $71 2
2023 General $827 37
2022 General $1,961 121
2021 General $1,774 106
2020 General $2,354 81
2019 General $1,047 56

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ghurulakshmi Moorthy
  • Internal Medicine median
  • Middle half of Internal Medicine
  • National median

In program year 2025, general payments to Ghurulakshmi Moorthy were reported at $0. Among 52,115 Internal Medicine profiles paid that year, the median was $156 and the middle half received between $47 and $551.

Show as a table
Year Ghurulakshmi Moorthy Internal Medicine median Middle half National median
2019 $1,047 $159 $48–$570 $163
2020 $2,354 $119 $33–$402 $114
2021 $1,774 $135 $37–$521 $132
2022 $1,961 $141 $42–$496 $149
2023 $827 $149 $45–$519 $160
2024 $71 $154 $47–$537 $164
2025 $0 $156 $47–$551 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Tandem Diabetes Care, Inc. $1,163 10 payments
  2. Novo Nordisk Inc $1,021 66 payments
  3. Lilly USA, LLC $566 34 payments
  4. Insulet Corporation $505 23 payments
  5. Abbott Laboratories $497 31 payments
  6. Sanofi-Aventis U.S. LLC $430 25 payments
  7. Xeris Pharmaceuticals, Inc. $427 22 payments
  8. Amgen Inc. $406 26 payments
  9. AbbVie, Inc. $368 24 payments
  10. Corcept Therapeutics $268 13 payments
  11. Other $2,385 129 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $7,017 398 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,000 3 payments
  3. Education $17 2 payments
Products named General payments · program years 2019–2024
  1. t:slim X2 insulin pump $1,000 3 payments
  2. Ozempic $837 53 payments
  3. RYBELSUS $782 50 payments
  4. Omnipod $445 21 payments
  5. GVOKE PFS $379 20 payments
  6. Korlym $268 13 payments
  7. JARDIANCE $262 15 payments
  8. Kerendia $260 14 payments
  9. EVENITY $253 16 payments
  10. Prolia $253 16 payments
  11. Other $4,688 271 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

403 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Internal Medicine in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record